Adam Rogers

Direttore/Membro del Consiglio presso NERVGEN PHARMA CORP.

Patrimonio netto: 14 300 $ in data 31/05/2024

Health Technology

Consumer Services

Posizioni attive di Adam Rogers

Società	Posizione	Inizio	Fine
NERVGEN PHARMA CORP.	Direttore/Membro del Consiglio	14/07/2022	-
NERVGEN PHARMA CORP.	Presidente	22/09/2022	10/04/2023
Hemera Biosciences, Inc. Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA.	Amministratore Delegato	01/01/2017	-
	Fondatore	01/01/2010	-
	Presidente	01/01/2010	01/01/2017
One Family, Inc.	Direttore/Membro del Consiglio	01/01/2007	-

Società	Posizione	Inizio	Fine
Emory University School of Medicine	Corporate Officer/Principal	-	02/01/1991

Emory University School of Medicine

Undergraduate Degree

Distribuzione geografica

Stati Uniti	4
Canada	2

Posizioni

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
NERVGEN PHARMA CORP.	Health Technology

Aziende private	2
Hemera Biosciences, Inc. Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA.	Health Technology
One Family, Inc.